CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modification

Abstract Osteosarcoma (OS) presents challenges due to its genomic instability and complexity, necessitating investigation into its oncogenesis and progression mechanisms. Recent studies have implicated m7G, a post-transcriptional modification, in the development of various cancers. However, research...

Full description

Saved in:
Bibliographic Details
Main Authors: Zili Lin, Ziyi Wu, Yizhe He, Xiangyao Li, Wei Luo
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Molecular Medicine
Subjects:
Online Access:https://doi.org/10.1186/s10020-025-01127-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850183869948493824
author Zili Lin
Ziyi Wu
Yizhe He
Xiangyao Li
Wei Luo
author_facet Zili Lin
Ziyi Wu
Yizhe He
Xiangyao Li
Wei Luo
author_sort Zili Lin
collection DOAJ
description Abstract Osteosarcoma (OS) presents challenges due to its genomic instability and complexity, necessitating investigation into its oncogenesis and progression mechanisms. Recent studies have implicated m7G, a post-transcriptional modification, in the development of various cancers. However, research on m7G modification in OS remains limited. This study aimed to explore the impact of m7G modification in OS, focusing on the role and mechanism of CYFIP1, a member of m7G cap binding complexes. Our findings demonstrated prominent anti-OS effects of CYFIP1 in vitro and vivo. Mechanistically, CYFIP1 collaborated with RNMT to induce the m7G methylation of AURKAIP1 mRNA, which resulted in the stability and the increasing translation of AURKAIP1 mRNA. AURKAIP1, a kind of mitochondrial small ribosomal subunit protein, exhibited increased expression, leading to the dysregulation of mitochondrial translation. This, in turn, caused an increase in the expression of FDX1, eventually triggering cuproptosis in OS cells and repressing OS occurrence and progression. In summary, our study identified the CYFIP1/RNMT/AURKAIP1/FDX1 axis as a potential therapeutic target for OS. These insights contribute to OS research and may guide the development of novel treatments for this challenging disease.
format Article
id doaj-art-8d46e85d5cdd4e9baf840ea8cefd23db
institution OA Journals
issn 1528-3658
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Molecular Medicine
spelling doaj-art-8d46e85d5cdd4e9baf840ea8cefd23db2025-08-20T02:17:13ZengBMCMolecular Medicine1528-36582025-02-0131111910.1186/s10020-025-01127-3CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modificationZili Lin0Ziyi Wu1Yizhe He2Xiangyao Li3Wei Luo4Department of Orthopaedics, Xiangya Hospital, Central South UniversityDepartment of Orthopaedics, The Second Xiangya Hospital, Central South UniversityDepartment of Orthopaedics, Xiangya Hospital, Central South UniversityDepartment of Orthopaedics, Xiangya Hospital, Central South UniversityDepartment of Orthopaedics, Xiangya Hospital, Central South UniversityAbstract Osteosarcoma (OS) presents challenges due to its genomic instability and complexity, necessitating investigation into its oncogenesis and progression mechanisms. Recent studies have implicated m7G, a post-transcriptional modification, in the development of various cancers. However, research on m7G modification in OS remains limited. This study aimed to explore the impact of m7G modification in OS, focusing on the role and mechanism of CYFIP1, a member of m7G cap binding complexes. Our findings demonstrated prominent anti-OS effects of CYFIP1 in vitro and vivo. Mechanistically, CYFIP1 collaborated with RNMT to induce the m7G methylation of AURKAIP1 mRNA, which resulted in the stability and the increasing translation of AURKAIP1 mRNA. AURKAIP1, a kind of mitochondrial small ribosomal subunit protein, exhibited increased expression, leading to the dysregulation of mitochondrial translation. This, in turn, caused an increase in the expression of FDX1, eventually triggering cuproptosis in OS cells and repressing OS occurrence and progression. In summary, our study identified the CYFIP1/RNMT/AURKAIP1/FDX1 axis as a potential therapeutic target for OS. These insights contribute to OS research and may guide the development of novel treatments for this challenging disease.https://doi.org/10.1186/s10020-025-01127-3AURKAIP1CuproptosisCYFIP1FDX1m7G modificationRNMT
spellingShingle Zili Lin
Ziyi Wu
Yizhe He
Xiangyao Li
Wei Luo
CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modification
Molecular Medicine
AURKAIP1
Cuproptosis
CYFIP1
FDX1
m7G modification
RNMT
title CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modification
title_full CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modification
title_fullStr CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modification
title_full_unstemmed CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modification
title_short CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modification
title_sort cyfip1 coordinate with rnmt to induce osteosarcoma cuproptosis via aurkaip1 m7g modification
topic AURKAIP1
Cuproptosis
CYFIP1
FDX1
m7G modification
RNMT
url https://doi.org/10.1186/s10020-025-01127-3
work_keys_str_mv AT zililin cyfip1coordinatewithrnmttoinduceosteosarcomacuproptosisviaaurkaip1m7gmodification
AT ziyiwu cyfip1coordinatewithrnmttoinduceosteosarcomacuproptosisviaaurkaip1m7gmodification
AT yizhehe cyfip1coordinatewithrnmttoinduceosteosarcomacuproptosisviaaurkaip1m7gmodification
AT xiangyaoli cyfip1coordinatewithrnmttoinduceosteosarcomacuproptosisviaaurkaip1m7gmodification
AT weiluo cyfip1coordinatewithrnmttoinduceosteosarcomacuproptosisviaaurkaip1m7gmodification